EUVIMEDEUVIMED entdecken
Fallbericht

Intralesional methotrexate and new approaches for neoadjuvance treatment in squamous cell periocular carcinoma

S López Montalbán, F Alarcón Soldevilla, S Abenza Baeza, M D Miranda Rollón, Á López Ávila, I Yago Ugarte

Archivos de la Sociedad Española de Oftalmología (English Edition) · 2024

DOI: 10.1016/j.oftale.2024.07.007 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Archivos de la Sociedad Española de Oftalmología (English Edition), 2024. Verfasst von S López Montalbán und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain. Electronic address: silvia.lopezm@um.es. Hauptthemen laut MEDLINE: Methotrexate, Carcinoma, Squamous Cell, Injections, Intralesional, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study arises from the need to understand the different therapies for cutaneous squamous cell carcinoma (SCC), especially in challenging clinical situations where conventional therapeutic options may not be optimal. The purpose of the study is to assess the efficacy and safety of intralesional methotrexate (MTX) as neoadjuvant therapy in the treatment of periocular SCC. The outcome of a patient after two separate intralesional MTX infiltrations 2 weeks apart is described. Therapeutic response was evaluated, achieving a significant reduction in tumor size and subsequently performing surgical excision of the residual lesion. The procedure was well tolerated, with no local or distant recurrences in the follow up. Intralesional MTX may be an effective and safe option in the neoadjuvant treatment of periocular SCC. Furthermore, we highlight the growing importance of immunotherapy in the approach to SCC and the need to familiarize specialists with these new treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateCarcinoma, Squamous CellInjections, IntralesionalAntimetabolites, AntineoplasticEyelid NeoplasmsHumansNeoadjuvant TherapyMaleSkin NeoplasmsAgedFemale

Stichwörter der Autor:innen

Carcinoma escamoso cutáneoCutaneous squamous cell carcinomaCáncer cutáneoEyelidsInmunoterapiaInmunotherapyIntralesional neoadjuvantNeoadyuvancia intralesionalPárpadosSkin cancer

Substanzen

MethotrexateAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain. Electronic address: silvia.lopezm@um.es.
  • Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain.
  • Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain.

Zitieren

APA

López Montalbán, S., Alarcón Soldevilla, F., Abenza Baeza, S., Miranda Rollón, M. D., López Ávila, Á., & Yago Ugarte, I. (2024). Intralesional methotrexate and new approaches for neoadjuvance treatment in squamous cell periocular carcinoma. Archivos de la Sociedad Española de Oftalmología (English Edition). https://doi.org/10.1016/j.oftale.2024.07.007

Vancouver

López Montalbán S, Alarcón Soldevilla F, Abenza Baeza S, Miranda Rollón MD, López Ávila Á, Yago Ugarte I. Intralesional methotrexate and new approaches for neoadjuvance treatment in squamous cell periocular carcinoma. Archivos de la Sociedad Española de Oftalmología (English Edition). 2024. doi:10.1016/j.oftale.2024.07.007

BibTeX
@article{LpezMontalbn2024,
  author = {López Montalbán, S and Alarcón Soldevilla, F and Abenza Baeza, S and Miranda Rollón, M D and López Ávila, Á and Yago Ugarte, I},
  title = {Intralesional methotrexate and new approaches for neoadjuvance treatment in squamous cell periocular carcinoma},
  journal = {Archivos de la Sociedad Española de Oftalmología (English Edition)},
  year = {2024},
  doi = {10.1016/j.oftale.2024.07.007}
}
Kostenlos starten →